In this regard, several studies have reported that milk derived EVs can ameliorate IBD in different in vivo models by suppressing immune cell infiltration and fibrosis, modulating MUC2 expression, reducing neutrophil activity, and promoting a pro-resolutive cytokine environment (19, 60, 64). Here, MUC2 is linked to inflammatory bowel disease.